Patients' Texas Anesthesia Rollup Suit Trimmed
A Texas federal judge offered patients a mixed bag Wednesday in a proposed class action accusing U.S. Anesthesia Partners Inc. of anticompetitively buying up anesthesia practices in the state and fixing prices... (more story)
Judge 'Flummoxed' By Forum Claim In IQVIA's Poaching Suit
A North Carolina Business Court judge said Thursday that he was "flummoxed" by clinical research giant IQVIA Holdings Inc.'s argument for not enforcing its own forum selection clause against four top executive... (more story)
Liquidia's Yutrepia Found To Infringe Lung Treatment Patent
A Delaware federal judge has ruled that Liquidia was infringing two claims of a patent covering methods of treating pulmonary hypertension associated with interstitial lung disease by seeking approval to marke... (more story)
3rd Circ. Topples Materiality Rule For Securities Suits
The Third Circuit on Wednesday revived a securities fraud class action against pharmaceutical company Ocugen Inc., scrapping a decades-old circuit rule that treated a stock price's failure to move after a corr... (more story)
Preparing For Broader Calif. Rules On PE Healthcare Deals
California's recent emergency regulations implementing expanded healthcare transaction review requirements, such as for private equity and hedge funds, represent a notable expansion of state oversight, includi... (more story)
Novo Bets $1.3B On Nanexa Drug Tech Amid Obesity Push
Novo Nordisk has agreed to pay up to about €1.165 billion ($1.3 billion) under an exclusive license and collaboration agreement for Swedish drug-delivery company Nanexa's PharmaShell technology.